BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

744 related articles for article (PubMed ID: 11889388)

  • 21. Differentiating the cause of acute sensorineural hearing loss between Ménière's disease and sudden deafness.
    Chen CN; Young YH
    Acta Otolaryngol; 2006 Jan; 126(1):25-31. PubMed ID: 16308251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
    Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
    Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Establishment of immunofluorescence for the testing serum antibodies against inner ear tissues and its clinical application].
    Gong S
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1992; 27(3):138-40, 189. PubMed ID: 1419189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoimmune sensorineural hearing loss: is it still a clinical diagnosis?
    Mathews J; Rao S; Kumar BN
    J Laryngol Otol; 2003 Mar; 117(3):212-4. PubMed ID: 12648380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Differential diagnosis of unilateral hearing loss].
    Reiss M; Reiss G
    Praxis (Bern 1994); 2000 Feb; 89(6):241-7. PubMed ID: 10783670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sudden sensorineural hearing loss: supporting the immunologic theory.
    Berrocal JR; Ramírez-Camacho R
    Ann Otol Rhinol Laryngol; 2002 Nov; 111(11):989-97. PubMed ID: 12450172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viral infection and serum antibodies to heat shock protein 70 in the acute phase of Ménière's disease.
    DiBerardino F; Cesarani A; Hahn A; Alpini D
    Int Tinnitus J; 2007; 13(2):90-3. PubMed ID: 18229786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiphospholipid inner ear syndrome.
    Mouadeb DA; Ruckenstein MJ
    Laryngoscope; 2005 May; 115(5):879-83. PubMed ID: 15867658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of immune assays for the detection of anti-HSP70 antibodies in patients with idiopathic sensorineural hearing loss.
    Tebo AE; Jaskowski TD; Keith LL; Litwin CM; Hill HR
    Clin Chim Acta; 2007 Jun; 381(2):140-4. PubMed ID: 17434470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The importance of IgG auto-antibodies, anti-collagen type II specific in Menière's disease and progressive hearing loss].
    Muiño JC; Carreras R; Ocampo MA; Ferrero M; Romero Piffiguer MD; Landa C; Beltramo D
    Rev Fac Cien Med Univ Nac Cordoba; 1999; 56(2):71-80. PubMed ID: 10883508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose oral methotrexate management of patients with bilateral Ménière's disease.
    Kilpatrick JK; Sismanis A; Spencer RF; Wise CM
    Ear Nose Throat J; 2000 Feb; 79(2):82-3, 86-8, 91-2. PubMed ID: 10697931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A study on serum autoantibodies against inner ear tissue in the blood of patients with inner ear disorders of unknown etiology].
    Xiao H; Gong S; Wang J
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(1):17-9. PubMed ID: 7598978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune-mediated sensorineural hearing loss.
    Veldman J
    Auris Nasus Larynx; 1998 Sep; 25(3):309-17. PubMed ID: 9799999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical associations of serum antiendothelial cell antibodies in patients with sudden sensorineural hearing loss.
    Cadoni G; Agostino S; Manna R; De Santis A; Fetoni AR; Vulpiani P; Ottaviani F
    Laryngoscope; 2003 May; 113(5):797-801. PubMed ID: 12792313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and clinical significance of anticardiolipin, anti-beta2-glycoprotein-1, and anti-heat shock protein-70 autoantibodies in sudden sensorineural hearing loss.
    Gross M; Eliashar R; Ben-Yaakov A; Ulmansky R; Elidan J
    Audiol Neurootol; 2008; 13(4):231-8. PubMed ID: 18259075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study.
    Matteson EL; Choi HK; Poe DS; Wise C; Lowe VJ; McDonald TJ; Rahman MU
    Arthritis Rheum; 2005 Jun; 53(3):337-42. PubMed ID: 15934127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognosis of sudden low-tone loss other than acute low-tone sensorineural hearing loss.
    Fushiki H; Junicho M; Kanazawa Y; Aso S; Watanabe Y
    Acta Otolaryngol; 2010 May; 130(5):559-64. PubMed ID: 19916896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical diagnosis of immune inner-ear disease.
    Hughes GB; Barna BP; Kinney SE; Calabrese LH; Nalepa NJ
    Laryngoscope; 1988 Mar; 98(3):251-3. PubMed ID: 3343873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoimmune inner ear disease--a real entity?
    Barna BP; Hughes GB
    Clin Lab Med; 1997 Sep; 17(3):581-94. PubMed ID: 9316775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.